抗肿瘤坏死因子-话题@MedSci - 梅斯（MedSci）

#抗肿瘤坏死因子#

88篇内容 | 2384人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1565828, encodeId=94471565828a4, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果, objectType=article, longId=205186, objectId=c06e2051867a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c06e2051867a, replyNumber=0, likeNumber=101, createdTime=2021-01-03, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c06e2051867a, moduleTitle=Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c06e2051867a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559819, encodeId=caa8155981939, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果, objectType=article, longId=205186, objectId=c06e2051867a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c06e2051867a, replyNumber=0, likeNumber=67, createdTime=2021-01-03, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c06e2051867a, moduleTitle=Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c06e2051867a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565827, encodeId=d974156582e75, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？, objectType=article, longId=202231, objectId=9c832022317d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c832022317d, replyNumber=0, likeNumber=82, createdTime=2020-10-19, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c832022317d, moduleTitle=TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c832022317d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559818, encodeId=8450155981809, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？, objectType=article, longId=202231, objectId=9c832022317d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c832022317d, replyNumber=0, likeNumber=0, createdTime=2020-10-19, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c832022317d, moduleTitle=TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9c832022317d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565826, encodeId=8f77156582677, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用, objectType=article, longId=201165, objectId=67352011653d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67352011653d, replyNumber=0, likeNumber=78, createdTime=2020-09-26, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67352011653d, moduleTitle=TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67352011653d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559817, encodeId=9c89155981efd, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用, objectType=article, longId=201165, objectId=67352011653d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67352011653d, replyNumber=0, likeNumber=65, createdTime=2020-09-26, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67352011653d, moduleTitle=TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67352011653d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565825, encodeId=8eca156582527, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响, objectType=article, longId=201008, objectId=c7d8201008d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7d8201008d6, replyNumber=0, likeNumber=63, createdTime=2020-09-23, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7d8201008d6, moduleTitle=AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c7d8201008d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559816, encodeId=bfc915598169d, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响, objectType=article, longId=201008, objectId=c7d8201008d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7d8201008d6, replyNumber=0, likeNumber=57, createdTime=2020-09-23, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7d8201008d6, moduleTitle=AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c7d8201008d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565824, encodeId=413c1565824f9, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, objectType=article, longId=198649, objectId=e55f19864904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55f19864904, replyNumber=0, likeNumber=94, createdTime=2020-08-05, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55f19864904, moduleTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e55f19864904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559815, encodeId=f839155981558, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, objectType=article, longId=198649, objectId=e55f19864904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55f19864904, replyNumber=0, likeNumber=76, createdTime=2020-08-05, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55f19864904, moduleTitle=IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e55f19864904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559814, encodeId=aed2155981424, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况, objectType=article, longId=188225, objectId=de4b188225a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de4b188225a5, replyNumber=0, likeNumber=49, createdTime=2020-02-18, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de4b188225a5, moduleTitle=JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=de4b188225a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565823, encodeId=341d156582312, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况, objectType=article, longId=188225, objectId=de4b188225a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de4b188225a5, replyNumber=0, likeNumber=51, createdTime=2020-02-18, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de4b188225a5, moduleTitle=JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=de4b188225a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565822, encodeId=48de1565822dd, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能, objectType=article, longId=186980, objectId=3f1c18698042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f1c18698042, replyNumber=0, likeNumber=71, createdTime=2020-01-31, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f1c18698042, moduleTitle=DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f1c18698042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559813, encodeId=cb3f155981359, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能, objectType=article, longId=186980, objectId=3f1c18698042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f1c18698042, replyNumber=0, likeNumber=70, createdTime=2020-01-31, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f1c18698042, moduleTitle=DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3f1c18698042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559812, encodeId=3293155981290, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, objectType=article, longId=186637, objectId=713418663e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713418663e69, replyNumber=0, likeNumber=0, createdTime=2020-01-24, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713418663e69, moduleTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=713418663e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565821, encodeId=c3671565821ee, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, objectType=article, longId=186637, objectId=713418663e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713418663e69, replyNumber=0, likeNumber=56, createdTime=2020-01-24, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713418663e69, moduleTitle=J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=713418663e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565820, encodeId=5ad9156582026, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗, objectType=article, longId=183864, objectId=048618386418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048618386418, replyNumber=0, likeNumber=60, createdTime=2019-12-02, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048618386418, moduleTitle=AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=048618386418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559811, encodeId=2075155981120, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗, objectType=article, longId=183864, objectId=048618386418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=048618386418, replyNumber=0, likeNumber=0, createdTime=2019-12-02, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=048618386418, moduleTitle=AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=048618386418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1559810, encodeId=bdd3155981028, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, objectType=article, longId=164331, objectId=cce81643312a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce81643312a, replyNumber=0, likeNumber=65, createdTime=2019-04-17, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce81643312a, moduleTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cce81643312a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1565819, encodeId=bb7715658199c, content=<a href='/topic/show?id=61785564089' target=_blank style='color:#2F92EE;'>#抗肿瘤坏死因子#</a>, objectTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, objectType=article, longId=164331, objectId=cce81643312a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cce81643312a, replyNumber=0, likeNumber=67, createdTime=2019-04-17, rootId=0, userName=zblhy, userId=1e7415021136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cce81643312a, moduleTitle=AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cce81643312a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗肿瘤坏死因子

2020-05-29

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果

2021-01-03

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

Clin cancer res：抗肿瘤坏死因子受体抗体MK-4166治疗晚期实体肿瘤的首次临床试验结果

2021-01-03

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？

2020-10-19

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

TAG: 补充铁是否可以增加抗肿瘤坏死因子-α药物治疗炎性肠病患者疗效？

2020-10-19

一叶知秋 (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用

2020-09-26

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

TAG：铁剂在接受抗肿瘤坏死因子-α药物治疗的炎症性肠病患者中的作用

2020-09-26

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响

2020-09-23

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T: 炎症性肠病患者使用抗肿瘤坏死因子药物以及硫唑嘌呤治疗对淋巴瘤发生风险的影响

2020-09-23

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率

2020-08-05

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

IBD：药物治疗监测可提高小儿克罗恩病患者抗肿瘤坏死因子α药物的保留率

2020-08-05

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况

2020-02-18

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

JCC：溃疡性结肠炎反应指数可预测抗肿瘤坏死因子治疗患者的粘膜愈合情况

2020-02-18

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能

2020-01-31

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

DCR：抗肿瘤坏死因子会增加UC手术患者术后储袋炎的可能

2020-01-31

仁心济世 (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究

2020-01-24

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

J Gastroenterology H：他克莫司联合抗肿瘤坏死因子α作为难治性溃疡性结肠炎缓解诱导疗法的回顾性研究

2020-01-24

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗

2019-12-02

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T：存在肛周克罗恩病患者需长期使用抗肿瘤坏死因子治疗

2019-12-02

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色

2019-04-17

zblhy (审核中...)

前往app查看评论内容

#抗肿瘤坏死因子#

AP&T：老年IBD患者使用抗肿瘤坏死因子α和维多珠单抗药物效果一样出色

2019-04-17

科室
- - 订阅+
  - 更多科室
工具
服务